Home > Healthcare > Allergic Rhinitis Drugs Market > Table of Contents

Allergic Rhinitis Drugs Market - By Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines) By Drug, By Route of Administration, By Distribution Channel & Forecast, 2023-2032

  • Report ID: GMI5413
  • Published Date: Jan 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Industry coverage

1.2    Market scope & definitions

1.3    Base estimates & working

1.3.1    Data collection

1.4    Forecast parameters

1.5    COVID-19 impact analysis at global level

1.6    Data validation

1.7    Data sources

1.7.1    Primary

1.7.2    Secondary

1.7.2.1   Paid sources

1.7.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Allergic rhinitis drugs industry 3600 synopsis, 2018 - 2032

2.2    Business trends

2.2.1    Disease type trends

2.2.2    Treatment type trends

2.2.3    Drug type trends

2.2.4    Route of administration trends

2.2.5    Distribution channel trends

2.2.6    Regional trends

Chapter 3   Allergic Rhinitis Drugs Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2018 – 2032

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Rising awareness about the allergic reactions and available treatment modes

3.3.1.2   Increasing prevalence of allergic rhinitis

3.3.1.3   Technological advancements in the field of allergy diagnosis and treatment

3.3.1.4   Growing pollution levels coupled with rise in respiratory disorders

3.3.2    Industry pitfalls & challenges

3.3.2.1   Side effects associated allergic rhinitis treatments

3.3.2.2   Similarity of symptoms with other diseases

3.4    Growth potential analysis

3.4.1    By disease type

3.4.2    By treatment type

3.4.3    By drug type

3.4.4    By route of administration

3.4.5    By distribution channel

3.5    COVID-19 impact analysis

3.6    Technology landscape

3.7    Drug approval scenario

3.8    Allergic Rhinitis: Causes and treatment scenario

3.9    Product pipeline analysis

3.10    List of drugs used in allergic rhinitis medication

3.11    Key market trends

3.12    Epidemiology scenario

3.13    Regulatory landscape

3.13.1    U.S.

3.13.2    Europe

3.14    Gap analysis

3.15    Reimbursement scenario

3.16    Porter’s analysis

3.17    PESTEL analysis

Chapter 4   Competitive Landscape, 2021

4.1    Introduction

4.2    Company matrix analysis, 2021

4.3    Competitive analysis of major market players

4.4    Competitive Positioning matrix

4.5    Strategy dashboard, 2021

Chapter 5   Allergic Rhinitis Drugs Market, By Disease Type

5.1    Key segment trends

5.2    Seasonal allergic rhinitis

5.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.3    Perennial allergic rhinitis

5.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.4    Occupational allergic rhinitis

5.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6   Allergic Rhinitis Drugs Market, By Treatment Type

6.1    Key segment trends

6.2    Antihistamines

6.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3    Immunotherapy

6.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.2    SCIT

6.3.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.3    SLIT

6.3.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.4    Corticosteroids

6.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.5    Decongestants

6.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.6    Others

6.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7   Allergic Rhinitis Drugs Market, By Drug Type

7.1    Key segment trends

7.2    Prescription

7.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.3    OTC

7.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8   Allergic Rhinitis Drugs Market, By Route of Administration

8.1    Key segment trends

8.2    Oral

8.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.3    Nasal

8.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.4    Intraocular

8.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.5    Intravenous

8.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9   Allergic Rhinitis Drugs Market, By Distribution Channel

9.1    Key segment trends

9.2    Retail pharmacies

9.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

9.3    Hospital pharmacies

9.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

9.4    Online channel

9.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 10   Allergic Rhinitis Drugs Market, By Region

10.1    Key regional trends

10.2    North America

10.2.1    U.S.

10.2.2    Canada

10.3    Europe

10.3.1    Germany

10.3.2    UK

10.3.3    France

10.3.4    Spain

10.3.5    Italy

10.4    Asia Pacific

10.4.1    China

10.4.2    Japan

10.4.3    India

10.4.4    Australia

10.4.5    South Korea

10.5    Latin America

10.5.1    Brazil

10.5.2    Mexico

10.5.3    Argentina

10.6    Middle East & Africa

10.6.1    South Africa

10.6.2    Saudi Arabia

10.6.3    UAE

Chapter 11   Company Profiles

11.1    Merck & Co.

11.2    Teva Pharmaceutical Industries Ltd.

11.3    GlaxoSmithKline PLC

11.4    Boehringer Ingelheim

11.5    Stallergenes Greer

11.6    Unichem Laboratories

11.7    Sanofi S.A.

11.8    Johnson & Johnson

11.9    Alcon (Novartis AG)

11.10    Mylan NV

11.11    Meda AB

11.12    Allergy Therapeutics PLC

11.13    Glenmark Pharmaceuticals Ltd

11.14    ALK-Abelló A/S

11.15    Bayer AG

11.16    Adamis Pharmaceuticals

11.17    Dr Reddy’s Laboratories

11.18    Sun Pharmaceuticals
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 18
  • Tables & Figures: 351
  • Countries covered: 18
  • Pages: 220
 Download PDF